Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay.

Liu AY, Charron J, Fugaro D, et al.  Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. J Cardiovasc Electrophysiol. 2023; 34:502‐506. doi:10.1111/jce.15819

In their March 2023 publication in the Journal of Cardiovascular Electrophysiology, Dr. Albert Liu et al reviewed data from 29 patients who were initiated on intravenous sotalol to examine feasibility, safety and length of stay for Sotalol IV.  IV sotalol loading had a safety profile similar to that of oral sotalol, while shortening length of stay (1.0 vs. 3.6 days for oral sotalol), potentially leading to large cost savings. https://pubmed.ncbi.nlm.nih.gov/36640424/